LAMP2 and cardiomyopathy: For example, a series of genetic studies uncovered the therapeutic effects of inhibiting the mammalian target of rapamycin (mTOR) in anemia-induced cardiomyopathy, DIC, a bag3 knockout cardiomyopathy model, and a lamp2 cardiomyopathy knockout model (Ding et al., 2011, 2016, 2019; Dvornikov et al., 2019).